These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28331227)

  • 1. ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.
    Dzikiewicz-Krawczyk A; Kok K; Slezak-Prochazka I; Robertus JL; Bruining J; Tayari MM; Rutgers B; de Jong D; Koerts J; Seitz A; Li J; Tillema B; Guikema JE; Nolte IM; Diepstra A; Visser L; Kluiver J; van den Berg A
    Leukemia; 2017 Jun; 31(6):1470-1473. PubMed ID: 28331227
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
    Ziel-Swier LJYM; Liu Y; Seitz A; de Jong D; Koerts J; Rutgers B; Veenstra R; Razak FRA; Dzikiewicz-Krawczyk A; van den Berg A; Kluiver J
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.
    De Falco G; Ambrosio MR; Fuligni F; Onnis A; Bellan C; Rocca BJ; Navari M; Etebari M; Mundo L; Gazaneo S; Facchetti F; Pileri SA; Leoncini L; Piccaluga PP
    BMC Cancer; 2015 Oct; 15():668. PubMed ID: 26453442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular ZDHHC11 supports Burkitt lymphoma growth independent of its miR-150 binding capacity.
    Liu Y; Zhao X; Seitz A; Hooijsma AA; Ravanbakhsh R; Sheveleva S; de Jong D; Koerts J; Dzikiewicz-Krawczyk A; van den Berg A; Ziel-Swier LJYM; Kluiver J
    Sci Rep; 2024 Apr; 14(1):8730. PubMed ID: 38627588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma.
    Robertus JL; Kluiver J; Weggemans C; Harms G; Reijmers RM; Swart Y; Kok K; Rosati S; Schuuring E; van Imhoff G; Pals ST; Kluin P; van den Berg A
    Br J Haematol; 2010 Jun; 149(6):896-9. PubMed ID: 20331457
    [No Abstract]   [Full Text] [Related]  

  • 8. Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
    Wang M; Yang W; Li M; Li Y
    Exp Mol Pathol; 2014 Apr; 96(2):261-6. PubMed ID: 24613688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway.
    Bueno MJ; Gómez de Cedrón M; Gómez-López G; Pérez de Castro I; Di Lisio L; Montes-Moreno S; Martínez N; Guerrero M; Sánchez-Martínez R; Santos J; Pisano DG; Piris MA; Fernández-Piqueras J; Malumbres M
    Blood; 2011 Jun; 117(23):6255-66. PubMed ID: 21478429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.
    Ferreira AC; Robaina MC; Rezende LM; Severino P; Klumb CE
    Ann Hematol; 2014 Jun; 93(6):983-93. PubMed ID: 24577510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
    Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
    Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.
    Kluiver J; van den Berg A; de Jong D; Blokzijl T; Harms G; Bouwman E; Jacobs S; Poppema S; Kroesen BJ
    Oncogene; 2007 May; 26(26):3769-76. PubMed ID: 17173072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
    Tagawa H; Karube K; Tsuzuki S; Ohshima K; Seto M
    Cancer Sci; 2007 Sep; 98(9):1482-90. PubMed ID: 17608773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.
    Robaina MC; Faccion RS; Mazzoccoli L; Rezende LM; Queiroga E; Bacchi CE; Thomas-Tikhonenko A; Klumb CE
    Ann Hematol; 2016 May; 95(6):881-91. PubMed ID: 27044389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
    Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
    Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous involvement with Burkitt-like lymphoma.
    Pettey AA; Walsh JS
    Am J Dermatopathol; 2007 Apr; 29(2):184-6. PubMed ID: 17414444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkitt lymphoma and MYC: what else is new?
    Said J; Lones M; Yea S
    Adv Anat Pathol; 2014 May; 21(3):160-5. PubMed ID: 24713985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.
    Greenough A; Dave SS
    Curr Opin Hematol; 2014 Jul; 21(4):326-32. PubMed ID: 24867287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of follicular lymphoma to Burkitt-like lymphoma within a single lymph node.
    Mukhopadhyay S; Readling J; Cotter PD; Shrimpton AE; Sidhu JS
    Hum Pathol; 2005 May; 36(5):571-5. PubMed ID: 15948125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.